TENX - Tenax TherapeuticsAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $2.58 | Open | $2.40 |
| Volume | 1.25M | Market Cap | 32.56M |
| Yield | Last Dividend |
| TENX Stock: 8 Things to Know About Tenax... | 01/19/21 |
| Tenax Therapeutics (TENX) stock is flying high on Tuesday after announcing it has acquired biotech company PH Precision Med. | |
| Tenax Therapeutics, Inc. Announces Trans... | 01/19/21 |
| Expands pipeline into Pulmonary Arterial Hypertension (PAH), a progressive, fatal orphan disease without a cure Imatinib, a tyrosine kinase inhibitor ... | |
| Tenax, Amphastar, Arcturus: Why These 3 ... | 12/29/20 |
| Tenax Therapeutics (NASDAQ: TENX ) shares were trading higher Tuesday after HC Wainwright & Co. initiated coverage of the stock with a Buy rating and ... | |
| Tenax Therapeutics Announces Presentatio... | 11/10/20 |
| MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (Nasdaq: TENX) announces HELP Study presented at American Heart Association (AHA) Scienti... | |
| Tenax Therapeutics to Host Virtual R&D W... | 11/06/20 |
| Tenax Therapeutics, Inc. (NASDAQ: TENX) will host a virtual R&D webinar for analysts and investors on Wednesday, November 18, 2020 at 4:30 p.m. EST | |
| Tenax Therapeutics Reports Second Quarte... | 08/17/20 |
| MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (Nasdaq: TENX), today reported financial results for the second quarter 2020 and provided... | |
| Tenax Therapeutics : 2019 Annual Report ... | 08/03/20 |
| Tenax Therapeutics is focused on providing valuable pharmaceutical products that address conditions with significant unmet medical needs. To Our??? | ... | |
| Tenax Therapeutics Expands Board of Dire... | 07/20/20 |
| MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (Nasdaq: TENX), announced the appointment of Steven Boyd and Keith Maher, M.D. to the Com... | |
| Tenax Therapeutics launches $8M direct o... | 07/07/20 |
| Tenax Therapeutics (NASDAQ:TENX) inks agreement with institutional investor for the issuance and sale of 2,523,611 common shares at a purchase price o... | |
| Thinking about buying stock in Tenax The... | 06/02/20 |
| NEW YORK, June 2, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TENX, ALNA, TRVN, ADAP, and ACB. To see how InvestorsOb... | |
| The Daily Biotech Pulse: ASCO Presentati... | 05/29/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 28) ADC ... | |
| Tenax Therapeutics Announces Last Patien... | 04/09/20 |
| MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX) announces last visit completed in Phase 2 levosimendan trial in PH-HFpEF. ... | |
| Tenax Therapeutics Announces $2.75 Milli... | 03/12/20 |
| MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX) Enters Agreement For $2.75 Million in Registered Direct Offering | |
| Tenax Announces the Addition of Mayo Cli... | 02/21/20 |
| MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX) adds Dr. Barry Borlaug of Mayo Clinic to scientific advisory board for Pha... | |
| Tenax Therapeutics Provides Update on Ph... | 10/31/19 |
| Tenax Therapeutics, Inc. (TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardi... | |
| Automakers, Macau Names And CinemaCon Ac... | 03/31/19 |
| No summary available. | |
| AZN and SGH among premarket losers | 03/29/19 |
| No summary available. | |
| Tenax Therapeutics and Fibrocell Science... | 03/28/19 |
| No summary available. | |
| Healthcare names top midday movers | 03/18/19 |
| No summary available. | |
| Dermira leads healthcare gainers; Tenax ... | 03/18/19 |
| No summary available. | |
| DKS and ADT among premarket losers | 03/12/19 |
| No summary available. | |
| Tenax down 6% on start of mid-stage stud... | 03/11/19 |
| No summary available. | |
| TrovaGene leads healthcare gainers; CHF ... | 03/08/19 |
| No summary available. | |
| 22nd Century Group and Tenax Therapeutic... | 03/06/19 |
| No summary available. | |
| Tenax Therapeutics up 26% | 03/01/19 |
| No summary available. | |
| Puma Biotechnology and Lexicon Pharmaceu... | 03/01/19 |
| No summary available. | |
| Buy rating | 12/29/20 |
| HC Wainwright & Co. initiates coverage with Buy rating and announces Price Target of $5.00 | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Option Superstars | James Catzen | 75.00 % | Subscribe |
| Mojo Day Trading | ProTrader Mike | 46.00 % | Subscribe |
| Mojo Day Trading | ProTrader Mike | 42.00 % | Subscribe |
| Symmetry Options | Symmetry Options | 33.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
